|
| |
New approaches to clinical trials in vascular dementia: memantine in small vessel disease.
Mobius HJ, Stoffler A.
Merz & Co.
Frankfurt, Germany.
hj.moebius@merz.de
Cerebrovasc Dis 2002;13 Suppl 2:61-6
Abstract
Although criteria for the diagnosis of vascular dementia (VaD) are established, the diagnostic concept is still controversial and there is no regulatory guidance for clinical drug development. Clinical trials in VaD present a number of pitfalls and challenges and, so far, no compound has received regulatory approval for this indication. The methodological issues of clinical VaD trials are discussed using the development of memantine for this indication as an example.
In a pooled analysis of two placebo-controlled trials with the NMDA-antagonist memantine in VaD, the cognitive benefit by memantine treatment was more pronounced for patients with 'small vessel disease' than for those with other neuroradiological findings at baseline.
In a subgroup of patients with 'large vessel disease' or macrolesions, there was less cognitive decline among the placebo patients.
It may therefore be helpful to use predefined diagnostic subcategories in clinical studies in this indication.
The findings further suggest that stroke or multiple infarctions may not be the primary reason for cognitive decline in VaD patients.
|
|
|
order
|
www.AlzheimersTreatments.com
|
Galantamine Alzheimer's
articles
Galantamine:
Boost Memory
Galantamine achieves the same effect as drugs such as
Aricept® or tacrine, but has additional benefits continue
Galantamine protects Brain funtion
The
primary objective with
Alzheimer's is to enhance neurotransmission so as to retain memory continue
Galantamine fights Alzheimer's
In
the 1950s, a Bulgarian pharmacologist noticed that local villagers rubbed their
foreheads with
the snowdrop plant to ease
nerve pain. Further investigation led to the isolation of the snowdrop extract
galantamine continue
Galantamine: why galantamine is the best agent for restoring memory
Galantamine has several advantages over donepezil (Aricept®) and rivastigmine (Exelon®)
continue
Galantamine: can sharpen your mental edge
Galantamine's positive results
in slowing the progression of Alzheimer's disease may be due continue
Galantamine: helps save Memory
Galantamine is used in treating Alzheimer's disease, because of its ability
continue
Galantamine: beats Prescription Drugs for
combating Mental Decline
Galantamine is different from donepezil (Aricept®) and rivastigmine (Exelon®) in one very important
way, galantamine has the unique ability to increase the receptiveness of nicotinic
receptors to acetylcholine continue
Galantamine: opens the channels of your Memory
The secret
of galantamine's success lies in your brain's nicotinic receptors. continue
Galantamine: Protect Brain Function by Enhancing Neurotransmission
Galantamine has been found to be effective in treating Alzheimer's
disease continue
Galantamine:
food for Mind & Body
Galantamine is a
flower extract that improves memory and perhaps even helps with impotence continue
Galantamine may help stave off Dementia
Dementia
is a progressive loss of memory accompanied by significant continue
Galantamine: Memory Enhancement
Alzheimer's patients suffer sharp declines in their brain levels of acetylcholine.
Galantamine continue
Galantamine rescues
Brain Cells
According to a study of 653 Alzheimer's disease
patients published in the
British Medical Journal, the herbal supplement galantamine
"appears to slow the progression of the neurodegenerative
condition" continue
Galantamine:
the Old Become Young
As we age, it becomes harder to
learn new things. One explanation is the deterioration of the brain's
continue
Galantamine: What's Old with Acetylcholine is New to Us
Acetylcholine
deficiency is
characteristic of Alzheimer's disease. The primary treatment is administration
of agents like galantamine, an extract from the snowdrop and
daffodil plants continue
|
|